Inventor
LAZARUS ROBERT A
US34 patents
⚠️ This page may combine multiple inventors who share the name “LAZARUS ROBERT A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
27 patentsUS5786328AJul 28, 1998
Use of kunitz type plasma kallikrein inhibitors
GENENTECH INC149 citations98
US5780265AJul 14, 1998
Kunitz type plasma kallikrein inhibitors
GENENTECH INC125 citations98
US5874407AFeb 23, 1999
Factor VIIA inhibitors
GENENTECH INC113 citations97
US5880256AMar 9, 1999
Factor VIIa inhibitors from Kunitz domain proteins
GENENTECH INC75 citations96
US5863893AJan 26, 1999
Factor VIIa inhibitors from kunitz domain proteins
GENENTECH INC66 citations96
US5834244ANov 10, 1998
Factor VIIa inhibitors from Kunitz domain proteins
GENENTECH INC82 citations96
US5795954AAug 18, 1998
Factor VIIa inhibitors from Kunitz domain proteins
GENENTECH INC81 citations96
US5736364AApr 7, 1998
Factor viia inhibitors
GENENTECH INC47 citations96
US6113896ASep 5, 2000
Pharmaceutical compositions containing ecotin and homologs thereof
GENENTECH INC80 citations95
US5843895ADec 1, 1998
Pharmaceutical administration of ecotin homologs
GENENTECH INC64 citations95
US5719041AFeb 17, 1998
DNA encoding ecotin homologs
GENENTECH INC67 citations95
US6391607B1May 21, 2002
Human DNase I hyperactive variants
GENENTECH INC74 citations94
US5032514AJul 16, 1991
Metabolic pathway engineering to increase production of ascorbic acid intermediates
GENENTECH INC76 citations93
US4757012AJul 12, 1988
Ascorbic acid intermediates and process enzymes
GENENTECH INC48 citations92
US7407785B2Aug 5, 2008
Human DNase I hyperactive variants
GENENTECH INC34 citations90
US7084109B2Aug 1, 2006
FVIIa antagonists
GENENTECH INC27 citations89
US6348343B2Feb 19, 2002
Human DNase I variants
GENENTECH INC48 citations89
US5227469AJul 13, 1993
Platelet aggregation inhibitors from the leech
GENENTECH INC33 citations87
US9453079B2Sep 27, 2016
Methods and compositions for neural disease immunotherapy
GENENTECH INC9 citations83
US7737115B2Jun 15, 2010
HGF beta chain variants
GENENTECH INC3 citations62
US9624269B2Apr 18, 2017
Peptide inhibitors of BACE1
GENENTECH INC0 citations52
US9193766B2Nov 24, 2015
Peptide inhibitors of BACE1
GENENTECH INC1 citations52
US9879094B2Jan 30, 2018
Nucleic acid molecules encoding for BACE1 antibodies
GENENTECH INC0 citations51
US10562946B2Feb 18, 2020
Chagasin-based scaffold compositions, methods, and uses
GENENTECH INC0 citations50
US7164002B2Jan 16, 2007
FVIIa antagonists
GENENTECH INC0 citations50
US10005848B2Jun 26, 2018
Method of reducing blood glucose by administering RON agonists
GENENTECH INC0 citations45
US8623821B2Jan 7, 2014
Zymogen activators
GENENTECH INC0 citations44
UNIV RUTGERS
4 patentsUS5376544ADec 27, 1994
Enzymes for the production of 2-keto-L-gulonic acid
UNIV RUTGERS52 citations95
US5912161AJun 15, 1999
Enzymes for the production of 2-keto-L-gulonic acid
UNIV RUTGERS18 citations92
US5583025ADec 10, 1996
Enzymes for the production of 2-keto-L-gulonic acid
UNIV RUTGERS26 citations92
US7256027B1Aug 14, 2007
Enzymes for the production of 2-keto-L-gulonic acid
UNIV RUTGERS1 citations51